Alyeska Investment Group, L.P. Jazz Pharmaceuticals PLC Transaction History
Alyeska Investment Group, L.P.
- $25.4 Billion
- Q2 2025
A detailed history of Alyeska Investment Group, L.P. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 203,868 shares of JAZZ stock, worth $27.5 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
203,868Holding current value
$27.5 Million% of portfolio
0.09%Shares
7 transactions
Others Institutions Holding JAZZ
# of Institutions
563Shares Held
62.5MCall Options Held
563KPut Options Held
77.8K-
Black Rock Inc. New York, NY6.15MShares$829 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$821 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$344 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$343 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$342 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.45B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...